Error: Could not add to watchlist. X
+ Watchlist

Fresenius Kabi USA Inc

APPX:US
Acquired
APPX:US was acquired by FRE:GR
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.70
Market Cap (USD)
-
Shares Outstanding (m)
160.793
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Fresenius Kabi USA, Inc. develops, manufactures, and markets specialty pharmaceutical products. The Company offers infusion pumps, cell processing, clinical nutrition, and oncology drugs. Fresenius Kabi USA conducts its business worldwide.
Address
3 Corporate Drive
Lake Zurich, IL 60047
United States
Phone
1-847-550-2300
Show More